Senseonics Holdings (SENS) Total Non-Current Liabilities (2014 - 2025)
Senseonics Holdings (SENS) reported Total Non-Current Liabilities of $61.8 million for Q3 2025, down 11.72% year-over-year from $70.0 million in Q3 2024, and up 11.17% quarter-over-quarter from $55.6 million in Q2 2025.
Senseonics Holdings (SENS) Total Non-Current Liabilities (2014 - 2025) Analysis & Trends
Senseonics Holdings (SENS) has 12 years of Total Non-Current Liabilities data on file, last reported at $61.8 million in Q3 2025.
- Total Non-Current Liabilities for Q3 2025 came in at $61.8 million, down 11.72% year-over-year; the trailing twelve-month figure through Sep 2025 was $61.8 million (down 11.72% YoY), and the FY2024 annual result was $73.6 million, up 13.74% from the prior year.
- Total Non-Current Liabilities climbed to $61.8 million in Q3 2025 per SENS's latest filing, from $55.6 million in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $546.7 million in Q2 2021 and troughed at $46.3 million in Q1 2025.
- A 5-year average of $125.8 million and a median of $70.0 million in 2024 frame the typical range for Total Non-Current Liabilities.
- The sharpest annual moves came in 2021 and 2022: Total Non-Current Liabilities surged 625.41% in 2021, then slumped 71.41% in 2022.
- A 5-year view of Total Non-Current Liabilities shows it stood at $315.1 million in 2021, then tumbled by 55.59% to $139.9 million in 2022, then tumbled by 53.78% to $64.7 million in 2023, then increased by 13.74% to $73.6 million in 2024, then declined by 16.03% to $61.8 million in 2025.
- Business Quant data shows SENS's Total Non-Current Liabilities at $61.8 million in Q3 2025, $55.6 million in Q2 2025, and $46.3 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 40.52 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 15.78 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 2.44 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 9.85 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 3.53 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 3.47 Bn |
| 10 | Senseonics Holdings | 309.99 Mn | 245.67 Mn | 6.94 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 61.76 Mn |
| Jun 30, 2025 | 55.55 Mn |
| Mar 31, 2025 | 46.35 Mn |
| Dec 31, 2024 | 73.55 Mn |
| Sep 30, 2024 | 69.96 Mn |
| Jun 30, 2024 | 67.32 Mn |
| Mar 31, 2024 | 63.78 Mn |
| Dec 31, 2023 | 64.67 Mn |
| Sep 30, 2023 | 64.10 Mn |
| Jun 30, 2023 | 61.38 Mn |
| Mar 31, 2023 | 54.33 Mn |
| Dec 31, 2022 | 139.90 Mn |
| Sep 30, 2022 | 113.94 Mn |
| Jun 30, 2022 | 156.33 Mn |
| Mar 31, 2022 | 127.56 Mn |
| Dec 31, 2021 | 315.06 Mn |
| Sep 30, 2021 | 168.97 Mn |
| Jun 30, 2021 | 546.72 Mn |
| Mar 31, 2021 | 138.83 Mn |
| Dec 31, 2020 | 115.07 Mn |